Page 130 - Fluorescence-guided cancer surgery

128
Chapter 8
25.
26.
27.
28.
29.
30.
31.
32.
Fang J, Nakamura H, Maeda H. The EPR e ect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the e ect. Adv Drug Deliv Rev 2011;63:136-151.
Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR e ect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci 2012;88:53- 71.
Mieog JS, Troyan SL, Hutteman M et al. Towards Optimization of Imaging System and Lymphatic Tracer for Near- Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer. Ann Surg Oncol 2011;18:2483-2491.
Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 2003;3:319-328.
Maeda H. The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR e ect. Cancer Sci 2013;104:779-789.
van der Vorst JR, Schaafsma BE, Hutteman M et al. Near-infrared uorescence-guided resection of colorectal liver metastases. Cancer 2013;119:3411-3418.
van der Vorst JR, Schaafsma BE, Verbeek FP et al. Intraoperative near-infrared uorescence imaging of parathyroid adenomas with use of low-dose methylene blue. Head Neck 2013.
Tummers QR, Verbeek FP, Schaafsma BE et al. Real-time intraoperative detection of breast cancer using near-infrared uorescence imaging and Methylene Blue. Eur J Surg Oncol 2014;40:850-858.